Unknown NA INTERVENTIONAL 2-arm NCT01385358

Catheter Versus Thoracoscopic Surgical Ablation Strategy in Persistent Atrial Fibrillation (CASA-AF)

A Study to Assess Catheter Ablation Versus Thoracoscopically Assisted Surgical Ablation in Persistent Atrial Fibrillation

Sponsor: Royal Brompton & Harefield NHS Foundation Trust

Conditions Persistent Atrial Fibrillation

Interventions Catheter Ablation Thoracoscopically Assisted Surgical Ablation

Updated 6 times since 2017 Last updated: Jun 29, 2011 Started: Apr 30, 2011 Primary completion: Oct 31, 2013 Completion: Oct 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Persistent Atrial Fibrillation and is currently ongoing. Royal Brompton & Harefield NHS Foundation Trust leads this study, which shows 6 recorded versions since 2011 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Jun 2018 — Jan 2021 [monthly]

Unknown Status NA
Feb 2017 — Jun 2018 [monthly]

Unknown Status NA

Status: Enrolling By Invitation → Unknown Status

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Enrolling By Invitation NA

First recorded

Apr 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Royal Brompton & Harefield NHS Foundation Trust

Data source: Royal Brompton & Harefield NHS Foundation Trust

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• London, United Kingdom